LINC01013: A Drug Target / Disease Biomarker (G100507254)

Target Name: LINC01013

NCBI ID: G100507254

LINC01013

Other Name(s): long intergenic non-protein coding RNA 1013 | Long intergenic non-protein coding RNA 1013, transcript variant 1

LINC01013: A Drug Target / Disease Biomarker

LINC01013 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the regulation of ion channels and neurotransmitter release. As a drug target, LINC01013 has the potential to be used to treat a variety of neurological and psychiatric disorders.

The protein LINC01013 is composed of 1,202 amino acids and has a calculated molecular mass of 19.9 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is also found in the placenta and testes. LINC01013 is a member of the protein family known as the SNAP (signal transduction adaptor) gene family, which includes a variety of proteins that play important roles in intracellular signaling.

One of the functions of LINC01013 is to regulate the activity of ion channels in various tissues. These channels are responsible for the movement of electrical impulses through the cell membrane, and their regulation is important for the proper functioning of many physiological processes. For example, in the brain, LINC01013 is known to regulate the activity of the Na+ channel, which is involved in the transmission of electrical signals.

In addition to its role in ion channel regulation, LINC01013 is also thought to be involved in the regulation of neurotransmitter release. These molecules are responsible for transmitting signals from the brain to other parts of the body, and their regulation is important for the proper functioning of many mental and neurological disorders. LINC01013 is known to be involved in the regulation of the release of neurotransmitters such as dopamine and serotonin.

The potential therapeutic uses of LINC01013 as a drug target are vast. Given its involvement in the regulation of ion channels and neurotransmitter release, LINC01013 may be useful for the treatment of a variety of neurological and psychiatric disorders. For example, LINC01013 has been shown to be involved in the development of symptoms of Alzheimer's disease, and may be a potential target for the development of Alzheimer's disease therapies. Additionally, LINC01013 may be useful for the treatment of other psychiatric disorders such as depression and anxiety, as it is thought to play a role in the regulation of neurotransmitter release.

In conclusion, LINC01013 is a protein that is expressed in various tissues throughout the body and is involved in the regulation of ion channels and neurotransmitter release. As a drug target, LINC01013 has the potential to be used to treat a variety of neurological and psychiatric disorders. Further research is needed to fully understand the function of LINC01013 and its potential therapeutic uses.

Protein Name: Long Intergenic Non-protein Coding RNA 1013

The "LINC01013 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01013 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets